Evidence map›Paper›PMID 31045501›Full record

Trial reportJournal of medical Internet research2019

Evaluating a Video-Based, Personalized Webpage in Genitourinary Oncology Clinical Trials: A Phase 2 Randomized Trial.

Rana McKay, Hannah Mills, Lillian Werner, Atish Choudhury, Toni Choueiri, Susanna Jacobus, Amanda Pace, Laura Polacek, Mark Pomerantz, Judith Prisby and 3 more

Open access · goldAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Journal of medical Internet research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Rana McKay *University of California San Diego, La Jolla, CA, United States.ORCID 0000-0002-0581-7963
Hannah Mills *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0002-0844-9975
Lillian WernerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0002-9063-0457
Atish ChoudhuryDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0001-9344-6631
Toni ChoueiriDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0002-9201-3217
Susanna JacobusDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0003-1951-5314
Amanda PaceDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0001-5360-4105
Laura PolacekDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0002-7106-0815
Mark PomerantzDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0003-4914-1157
Judith PrisbyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0001-9380-1947
Christopher SweeneyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0002-0398-6018
Meghara WalshDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0003-0847-2734
Mary-Ellen TaplinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0002-3384-0300
Dana-Farber Cancer Institute · USUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe pace of drug discovery and approvals has led to expanding treatments for cancer patients. Although extensive research exists regarding barriers to enrollment in oncology clinical trials, there are limited studies evaluating processes to optimize patient education, oral anticancer therapy administration, and adherence for patients enrolled in clinical trials. In this study, we assess the feasibility of a video-based, personalized webpage for patients enrolled in genitourinary oncology clinical trials involving 1 or more oral anticancer therapy.

objectiveThe primary objective of this trial was to assess the differences in the number of patient-initiated violations in the intervention arm compared with a control arm over 4 treatment cycles. Secondary objectives included patient satisfaction, frequently asked questions by patients on the intervention arm, patient-initiated calls to study team members, and patient-reported stress levels.

methodsEligible patients enrolling on a therapeutic clinical trial for a genitourinary malignancy were randomized 2:1 to the intervention arm or control arm. Patients randomized to the intervention arm received access to a video-based, personalized webpage, which included videos of patients' own clinic encounters with their providers, instructional videos on medication administration and side effects, and electronic versions of educational documents.

resultsA total of 99 patients were enrolled (89 were evaluable; 66 completed 4 cycles). In total, 71% (40/56) of patients in the intervention arm had 1 or more patient-initiated violation compared with 70% (23/33) in the control arm. There was no difference in the total number of violations across 4 cycles between the 2 arms (estimate=-0.0939, 95% CI-0.6295 to 0.4418, P value=.73). Median baseline satisfaction scores for the intervention and control arms were 72 and 73, respectively, indicating high levels of patient satisfaction in both arms. Median baseline patient-reported stress levels were 10 and 13 for the intervention and control arms, respectively, indicating low stress levels in both arms at baseline.

conclusionsThis study is among the first to evaluate a video-based, personalized webpage that provides patients with educational videos and video recordings of clinical trial appointments. Despite not meeting the primary endpoint of reduced patient-initiated violations, this study demonstrates the feasibility of a video-based, personalized webpage in clinical trials. Future research assessing this tool might be better suited for realms outside of clinical trials and might consider the use of an endpoint that assesses patient-reported outcomes directly. A major limitation of this study was the lack of prior data for estimating the null hypothesis in this population.

Indexed as

FemaleHumansInternetMaleUrogenital NeoplasmsVideo Recordingcancerclinical trialeducationinstructional films and videoskidney neoplasmsprostatic neoplasms

Identifiers

PMID31045501
PMCPMC6538310
OpenAlexW2908155516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.